Publications
Detailed Information
Increased CA 19-9 level in patients without malignant disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hye-Ryoun | - |
dc.contributor.author | Lee, Chang-Hyun | - |
dc.contributor.author | Kim, Young Whan | - |
dc.contributor.author | Han, Sung Koo | - |
dc.contributor.author | Yim, Jae-Joon | - |
dc.contributor.author | Shim, Young-Soo | - |
dc.date.accessioned | 2012-07-02T06:26:01Z | - |
dc.date.available | 2012-07-02T06:26:01Z | - |
dc.date.issued | 2009-06 | - |
dc.identifier.citation | CLINICAL CHEMISTRY AND LABORATORY MEDICINE; Vol.47 6; 750-754 | ko_KR |
dc.identifier.issn | 1434-6621 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78099 | - |
dc.description.abstract | Background: The measurement of carbohydrate antigen 19-9 (CA 19-9) is recommended for the diagnosis and follow-up of pancreatic cancer. However, increased CA 19-9 has also been reported in patients with various benign diseases of the lung. We aimed to elucidate the pulmonary radiographic abnormalities and laboratory results associated with increased concentrations of CA 19-9. Methods: This study was performed using a case-controlled design. Cases included all participants in a cancer screening program who had an increased CA 19-9 concentration (> 37 U/mL), but without a diagnosis of malignancy. Age- and sex-matched participants with normal CA 19-9 levels were enrolled as controls. Laboratory results and radiographic features were compared. Results: In total, 119 participants with increased CA 19-9 concentrations and 476 controls were included. A higher erythrocyte sedimentation rate (ESR) [adjusted odd ratio (aOR), 1.03; 95% confidence interval (CI), 1.01-1.05], higher hemoglobin A(1c) (HbA(1c)) (aOR, 1.28; 95% CI, 1.05-1.56), bronchiectasis (aOR, 2.48; 95% CI, 1.22-5.02), bronchiolitis (aOR, 3.93; 95% CI, 1.88-8.22), emphysema (aOR, 2.67; 95% CI, 1.32-5.40), and interstitial fibrosis (aOR, 10.62; 95% CI, 2.03-55.44) were independent factors for increased CA 19-9. Conclusions: CA 19-9 concentrations, as well as increased ESR and HbA(1c), can be increased in patients with various lung abnormalities. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | WALTER DE GRUYTER & CO | ko_KR |
dc.subject | bronchiectasis | ko_KR |
dc.subject | pulmonary fibrosis | ko_KR |
dc.subject | emphysema | ko_KR |
dc.subject | bronchiolitis | ko_KR |
dc.subject | carbohydrate antigen 19-9 (CA 19-9) antigen | ko_KR |
dc.title | Increased CA 19-9 level in patients without malignant disease | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 김혜련 | - |
dc.contributor.AlternativeAuthor | 이창현 | - |
dc.contributor.AlternativeAuthor | 김영환 | - |
dc.contributor.AlternativeAuthor | 한성구 | - |
dc.contributor.AlternativeAuthor | 심영수 | - |
dc.contributor.AlternativeAuthor | 임재준 | - |
dc.identifier.doi | 10.1515/CCLM.2009.152 | - |
dc.citation.journaltitle | CLINICAL CHEMISTRY AND LABORATORY MEDICINE | - |
dc.description.citedreference | Hansell DM, 2008, RADIOLOGY, V246, P697 | - |
dc.description.citedreference | Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243 | - |
dc.description.citedreference | Uygur-Bayramicli O, 2007, WORLD J GASTROENTERO, V13, P5357 | - |
dc.description.citedreference | Gotway MB, 2007, THORAX, V62, P546, DOI 10.1136/thx.2004.040022 | - |
dc.description.citedreference | Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004 | - |
dc.description.citedreference | Szekanecz E, 2007, ANN NY ACAD SCI, V1108, P359, DOI 10.1196/annals.1422.037 | - |
dc.description.citedreference | Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644 | - |
dc.description.citedreference | Mita T, 2006, ENDOCR J, V53, P693 | - |
dc.description.citedreference | Giannaris M, 2006, J CLIN GASTROENTEROL, V40, P657 | - |
dc.description.citedreference | Boeck S, 2006, ONCOLOGY-BASEL, V70, P255, DOI 10.1159/000094888 | - |
dc.description.citedreference | Parra JL, 2005, DIGEST DIS SCI, V50, P694, DOI 10.1007/s10620-005-2559-z | - |
dc.description.citedreference | Watanabe K, 2003, RESP MED, V97, P654, DOI 10.1053/rmed.2003.1496 | - |
dc.description.citedreference | Nakajima T, 2002, INTERNAL MED, V41, P225 | - |
dc.description.citedreference | BARKER AF, 2002, BRONCHIECTASIS N ENG, V346, P1383 | - |
dc.description.citedreference | Nakamura T, 2002, SURG TODAY, V32, P282 | - |
dc.description.citedreference | Akdogan M, 2001, TUMORI, V87, P337 | - |
dc.description.citedreference | YOKOYAMA A, 1998, RESPIROLOGY, V3, P199 | - |
dc.description.citedreference | MOZAS J, 1994, INT J GYNECOL OBSTET, V44, P53 | - |
dc.description.citedreference | IM JG, 1993, RADIOLOGY, V186, P653 | - |
dc.description.citedreference | BENHAMOU PY, 1991, DIABETES METAB, V17, P39 | - |
dc.description.citedreference | AOKI Y, 1991, DIABETES RES CLIN PR, V13, P77 | - |
dc.description.citedreference | SHIMOMURA C, 1989, J RHEUMATOL, V16, P1410 | - |
dc.description.citedreference | UYAMA T, 1989, J THORAC IMAG, V4, P74 | - |
dc.description.citedreference | TEMPERO MA, 1987, CANCER RES, V47, P5501 | - |
dc.description.citedreference | DUFFY MJ, 1985, CLIN CHEM, V31, P1245 | - |
dc.description.citedreference | DELVILLANO BC, 1983, CLIN CHEM, V29, P549 | - |
dc.description.citedreference | KOPROWSKI H, 1981, SCIENCE, V212, P53 | - |
dc.description.citedreference | KOPROWSKI H, 1979, SOMAT CELL GENET, V5, P957 | - |
dc.description.tc | 5 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.